Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -49.2% | 85.4% | -0.4% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -63.3% | -16.2% | -170.8% | -189.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -501% | -45.1% | -1,523.4% | -2,062.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -442.9% | -81.7% | -1,384.8% | -1,869% |
| EPS Diluted | -1 | -0.36 | -3.32 | -5.1 |
| % Growth | -177.8% | 89.2% | 34.9% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |